MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-14-0018470
Sowilo India Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.69 Cr
▲ 35% YoY
Net profit · FY 2025
₹11.21 Lakh
Net margin 2%
EBITDA · FY 2025
₹21.57 Lakh
EBITDA margin 3.8%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Open charges
₹60.68 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
30
Provident fund records
About Sowilo India Pharmaceuticals Private Limited
Data last updated:
Sowilo India Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2018PTC340658. Its GSTIN is 09ABBCS0137K1ZC (Uttar Pradesh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors including Savita Tiwari and Poonam Srivastava.
Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No – 27/110/2 Gali No – 6 Block – E West Karawal Nagar, Delhi, India – 110094.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.69 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹11.21 Lakh (net margin 2%) and EBITDA of ₹21.57 Lakh (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 51% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹60.68 Lakh on record.
Sowilo India Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-14-0018470). For more details, the company can be reached via its website sowiloindia.com.
Company details
CIN U51909DL2018PTC340658
Registration Number 340658
Incorporation Date 17 October 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-UP-14-0018470
Recognitions & Rankings of Sowilo India Pharmaceuticals
Contact details
Sowilo India Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is sowiloindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No – 27/110/2 Gali No – 6 Block – E West Karawal Nagar, Delhi, India – 110094
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sowilo India Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sowilo India Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sowilo India Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sowilo India Pharmaceuticals Private Limited, buy the company report.
Financials of Sowilo India Pharmaceuticals Private Limited
FY 2024 filings availableSowilo India Pharmaceuticals Private Limited reported revenue of ₹5.69 Cr (up 35% YoY) for FY 2025.
Revenue · FY 2025
₹5.69 Cr ▲ 35%
Net profit · FY 2025
₹11.21 Lakh margin 2%
EBITDA · FY 2025
₹21.57 Lakh margin 3.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 34%
5 years · compounded
▲ 51%
EBITDA CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 32%
5 years · compounded
▲ 56%
Revenue has grown at a compounded annual rate (CAGR) of 51% over five years, including 35% growth in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.21 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sowilo India Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sowilo India Pharmaceuticals Private Limited
Sowilo India Pharmaceuticals has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Savita Tiwari | Director | 17 Oct 2018 | 8 Years 0 Months | Current |
| Poonam Srivastava | Director | 17 Oct 2018 | 8 Years 0 Months | Current |
| Tripti Shukla | Director | 11 Jun 2021 | 5 Years 4 Months | Current |
| Jatin Trivedi | Director | 13 Aug 2019 | 7 Years 2 Months | Current |
Peer comparison
Sowilo India Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Affluential Pharmaceuticals Private Limited | ₹5.72 Cr (FY 2025) | 40.0% | Secunderabad, Telangana, India | |||
| Actiza Pharmaceutical Private Limited | ₹5.71 Cr (FY 2025) | 23.0% | Surat, Gujarat, India | |||
| Sowilo India Pharmaceuticals Private Limitedthis company | ₹5.69 Cr (FY 2025) | ₹11.21 Lakh | 2% | 35.0% | 30 | Delhi, India |
| Suyog Pharmaceuticals Private Limited | ₹5.69 Cr (FY 2025) | 25.0% | Thane, Maharashtra, India | |||
| Genova Biotechniques Private Limited | ₹5.69 Cr (FY 2025) | -6.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Sowilo India Pharmaceuticals Private Limited, buy the company report.
Auditor
Sowilo India Pharmaceuticals Private Limited is audited by ABHAY C. ASKNANI & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABHAY C. ASKNANI & CO. | FY 2023 | 136090W |
Shareholding
The shareholding of Sowilo India Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sowilo India Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹60.68 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2024 | 101053533 | Hdfc Bank Limited | ₹21.89 Lakh | Open | |
| 06 Jul 2023 | 100751743 | Hdfc Bank Limited | ₹25 Lakh | Open | |
| 30 Apr 2021 | 100455491 | Hdfc Bank Limited | ₹13.79 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Sowilo India Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sowilo India Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sowilo India Pharmaceuticals Private Limited has a workforce of 30 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
30
Active EPFO establishments
1
Employee growth
7.14%
GST
Sowilo India Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09ABBCS0137K1ZC | Uttar Pradesh | Active | 23 Jul 2019 |
To see the full GST registrations and return filing status of Sowilo India Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sowilo India Pharmaceuticals Private Limited has 4 board changes on record since 2018: 4 appointments. The latest: Tripti Shukla was appointed as Director on 11 Jun 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 21.89 Lakh with Charge ID 101053533 was registered on 31 Dec 2024.
AGM
Sowilo India Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records.
Filing
Sowilo India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.00 Lakh with Charge ID 100751743 was registered on 06 Jul 2023.
Appointed
Tripti Shukla was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.79 Lakh with Charge ID 100455491 was registered on 30 Apr 2021.
Appointed
Jatin Trivedi was appointed as Director.
Appointed
Poonam Srivastava was appointed as Director.
Appointed
Savita Tiwari was appointed as Director.
Incorporation
17 Oct 2018
Sowilo India Pharmaceuticals Private Limited was registered on 17 Oct 2018 with Roc Delhi & aged 8 years 19 days as per MCA records.
Frequently asked questions
Sowilo India Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 October 2018 (8+ years old) and is registered under CIN U51909DL2018PTC340658.
Sowilo India Pharmaceuticals has 4 current directors:
- Savita Tiwari - Director
- Poonam Srivastava - Director
- Tripti Shukla - Director
- Jatin Trivedi - Director
The latest financial statements of Sowilo India Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Sowilo India Pharmaceuticals is 09ABBCS0137K1ZC, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Sowilo India Pharmaceuticals is U51909DL2018PTC340658. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sowilo India Pharmaceuticals was incorporated on 17 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sowilo India Pharmaceuticals by revenue are Affluential Pharmaceuticals Private Limited, Actiza Pharmaceutical Private Limited, Suyog Pharmaceuticals Private Limited, Genova Biotechniques Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Tripti Shukla was appointed as Director on 11 Jun 2021. Jatin Trivedi was appointed as Director on 13 Aug 2019. Poonam Srivastava was appointed as Director on 17 Oct 2018. Sowilo India Pharmaceuticals has 4 board changes on record in total.
Yes, Sowilo India Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-14-0018470).
Sowilo India Pharmaceuticals can be reached through the website sowiloindia.com. Its registered office is in Delhi, India.
The registered office of Sowilo India Pharmaceuticals is at H.No – 271102 Gali No – 6 Block – E West Karawal Nagar, Delhi, India – 110094.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages